Philippe M. Maitre

Philippe M. Maitre discloses dealings in Oscient Pharmaceuticals Corp to SEC (Form 4). In total, 9 filings cover trades dated from 22 May 2006 to 25 February 2008.

Purchases make up the whole of the open-market record (3 purchases, €15k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 3 share grants. In 2008 alone, the filings show 1 purchase and no sales.

In size, the median ticket on the buying side is €5,852.

Most recently, on 13 March 2008, the filings show a share grant in Oscient Pharmaceuticals Corp. The latest purchase dates back some time: it was published 6,828 days ago, on 12 February 2008. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.